
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 924 | 924 | 1121 | 1414 | 2405 | 3467 |
Fund Return | -7.56% | -7.56% | 12.14% | 12.25% | 19.19% | 13.24% |
Place in category | 917 | 917 | 405 | 349 | 63 | 59 |
% in Category | 82 | 82 | 39 | 37 | 6 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AGF Global Select Series F CAD | 5.12B | -3.43 | 12.17 | 15.04 | ||
AGF American Growth Class CAD | 3.37B | -7.56 | 12.19 | 13.15 | ||
AGF Global Dividend Fund CAD | 2.29B | 4.16 | 12.14 | 7.41 | ||
AGF Global Dividend Fund Series CAD | 2.29B | 4.48 | 13.47 | 8.66 | ||
AGF Global Dividend Fund Series Q | 2.29B | 4.77 | 14.84 | 9.98 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PH N US Multi Style All Cap Eq D | 9.07B | -4.86 | 13.35 | 11.76 | ||
PH N US Multi Style All Cap Eq F | 9.07B | -4.80 | 13.62 | 12.03 | ||
DFA US Core Equity Class F CAD | 5.73B | -3.82 | 12.64 | 11.62 | ||
CIBC US Index Premium Class | 4.65B | -4.32 | 13.46 | 13.13 | ||
CIBC US Index | 4.65B | -4.49 | 12.64 | 12.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.09 | 110.93 | +3.12% | |
Amazon.com | US0231351067 | 6.94 | 184.87 | +2.01% | |
Boston Scientific | US1011371077 | 5.01 | 93.67 | +1.11% | |
Intuitive Surgical | US46120E6023 | 4.62 | 493.60 | +0.83% | |
Eli Lilly | US5324571083 | 4.13 | 732.41 | +1.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review